Search Results

There are 5798 results for: content related to: Open-Label Study on the Long-Term Efficacy, Safety, and Impact on Quality of Life of OROS Hydromorphone ER in Patients with Chronic Low Back Pain

  1. Hydromorphone for cancer pain

    Intervention Review

    The Cochrane Library

    Yan J Bao, Wei Hou, Xiang Y Kong, Liping Yang, Jun Xia, Bao J Hua and Roger Knaggs

    Published Online : 11 OCT 2016, DOI: 10.1002/14651858.CD011108.pub2

  2. Single-dose evaluation of safety, tolerability and pharmacokinetics of newly formulated hydromorphone immediate-release and hydrophilic matrix extended-release tablets in healthy Japanese subjects without co-administration of an opioid antagonist

    The Journal of Clinical Pharmacology

    Volume 55, Issue 9, September 2015, Pages: 975–984, Kaoru Toyama, Naoki Uchida, Hitoshi Ishizuka, Takehiko Sambe and Shinichi Kobayashi

    Version of Record online : 6 MAY 2015, DOI: 10.1002/jcph.501

  3. Pharmacokinetics of a controlled-release liposome-encapsulated hydromorphone administered to healthy dogs

    Journal of Veterinary Pharmacology and Therapeutics

    Volume 31, Issue 5, October 2008, Pages: 415–422, L. J. SMITH, B. KuKANICH, B. K. HOGAN, C. BROWN, T. D. HEATH and L. A. KRUGNER-HIGBY

    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1365-2885.2008.00974.x

  4. Results of a Double-blind, Placebo-controlled, Fixed-dose Assessment of Once-daily OROS® Hydromorphone ER in Patients with Moderate to Severe Pain Associated with Chronic Osteoarthritis

    Pain Practice

    Volume 13, Issue 1, January 2013, Pages: 18–29, Richard Rauck, Ronald Rapoport and John Thipphawong

    Version of Record online : 27 APR 2012, DOI: 10.1111/j.1533-2500.2012.00555.x

  5. Comparative Effects of Morning vs Evening Dosing of Extended-Release Hydromorphone on Sleep Physiology in Patients with Low Back Pain: A Pilot Study

    Pain Medicine

    Volume 16, Issue 3, March 2015, Pages: 460–471, Lynn R. Webster, Michael D. Smith, Sam Mackin and Matthew Iverson

    Version of Record online : 3 OCT 2014, DOI: 10.1111/pme.12577

  6. Primary Hydromorphone-Related Intrathecal Catheter Tip Granulomas: Is There a Role for Dose and Concentration?

    Neuromodulation: Technology at the Neural Interface

    Volume 19, Issue 7, October 2016, Pages: 760–769, I. Elias Veizi, Salim M. Hayek, Michael Hanes, Ryan Galica, Sivakanth Katta and Tony Yaksh

    Version of Record online : 9 AUG 2016, DOI: 10.1111/ner.12481

  7. Sustained Safety and Efficacy of Once-Daily Hydromorphone Extended-Release (OROS® hydromorphone ER) Compared with Twice-Daily Oxycodone Controlled-Release Over 52 Weeks in Patients with Moderate to Severe Chronic Noncancer Pain

    Pain Practice

    Volume 13, Issue 1, January 2013, Pages: 30–40, Ute Richarz, Sandra Waechter, Rainer Sabatowski, Leszek Szczepanski and Heinrich Binsfeld

    Version of Record online : 18 APR 2012, DOI: 10.1111/j.1533-2500.2012.00553.x

  8. Continuous Intrathecal Infusion of Hydromorphone: Safety in the Sheep Model and Clinical Implications

    Pain Medicine

    Volume 5, Issue 1, March 2004, Pages: 14–25, Mary J. Johansen, William C. Satterfield, Wallace B. Baze, Keith R. Hildebrand, Tamara Lee Gradert and Samuel J. Hassenbusch

    Version of Record online : 18 FEB 2004, DOI: 10.1111/j.1526-4637.2004.04010.x

  9. A Randomized Study of the Effects of Food on the Pharmacokinetics of Once-Daily Extended-Release Hydromorphone in Healthy Volunteers

    The Journal of Clinical Pharmacology

    Volume 51, Issue 11, November 2011, Pages: 1571–1579, Mr Kenneth Todd Moore, Ms Dominique St-Fleur, Ms Nadia Cardillo Marricco, Mr Jay Ariyawansa, Ms Véronique Pagé, Dr Jayalakshmi Natarajan, Dr Gaetano Morelli and Dr Ute Richarz

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010383858

  10. The effect of UGT2B7*2 polymorphism on the pharmacokinetics of OROS® hydromorphone in Taiwanese subjects

    The Journal of Clinical Pharmacology

    Volume 54, Issue 10, October 2014, Pages: 1170–1179, Joris Vandenbossche, Henry Richards, Stephan Francke, An Van Den Bergh, Chih Cherng Lu and Monique A. Franc

    Version of Record online : 15 APR 2014, DOI: 10.1002/jcph.305

  11. A Randomized Study to Demonstrate Noninferiority of Once-Daily OROS® Hydromorphone with Twice-Daily Sustained-Release Oxycodone for Moderate to Severe Chronic Noncancer Pain

    Pain Practice

    Volume 10, Issue 5, September/October 2010, Pages: 404–415, Heinrich Binsfeld, Leszek Szczepanski, Sandra Waechter, Ute Richarz and Rainer Sabatowski

    Version of Record online : 5 APR 2010, DOI: 10.1111/j.1533-2500.2009.00342.x

  12. Hydromorphone for neuropathic pain in adults

    Intervention Review

    The Cochrane Library

    Cathy Stannard, Helen Gaskell, Sheena Derry, Dominic Aldington, Peter Cole, Tess E Cooper, Roger Knaggs, Philip J Wiffen and R Andrew Moore

    Published Online : 24 MAY 2016, DOI: 10.1002/14651858.CD011604.pub2

  13. Novel Polymeric Bioerodable Microparticles for Prolonged-Release Intrathecal Delivery of Analgesic Agents for Relief of Intractable Cancer-Related Pain

    Journal of Pharmaceutical Sciences

    Volume 104, Issue 7, July 2015, Pages: 2334–2344, Felicity Y. Han, Kristofer J. Thurecht, Ai-Leen Lam, Andrew K. Whittaker and Maree T. Smith

    Version of Record online : 19 MAY 2015, DOI: 10.1002/jps.24497

  14. You have full text access to this OnlineOpen article
    Once-daily OROS® hydromorphone for the management of chronic nonmalignant pain: a dose-conversion and titration study

    International Journal of Clinical Practice

    Volume 61, Issue 10, October 2007, Pages: 1671–1676, M. Wallace, R. L. Rauck, D. Moulin, J. Thipphawong, S. Khanna and I. C. Tudor

    Version of Record online : 14 SEP 2007, DOI: 10.1111/j.1742-1241.2007.01500.x

  15. Pharmacokinetic and pharmacodynamic evaluation of intravenous hydromorphone in cats

    Journal of Veterinary Pharmacology and Therapeutics

    Volume 27, Issue 5, October 2004, Pages: 329–336, K. Wegner, S. A. Robertson, C. Kollias-Baker, R. A. Sams and W. W. Muir III

    Version of Record online : 20 OCT 2004, DOI: 10.1111/j.1365-2885.2004.00593.x

  16. Pharmacokinetics and physiological effects of intravenous hydromorphone in conscious dogs

    Journal of Veterinary Pharmacology and Therapeutics

    Volume 31, Issue 4, August 2008, Pages: 334–343, A. G. P. GUEDES, M. G. PAPICH, E. P. RUDE and M. A. RIDER

    Version of Record online : 15 MAY 2008, DOI: 10.1111/j.1365-2885.2008.00966.x

  17. Intrathecal Hydromorphone for Intractable Nonmalignant Pain: A Retrospective Study

    Pain Medicine

    Volume 7, Issue 1, January 2006, Pages: 10–15, Stuart Du Pen, Anna Du Pen and Jon Hillyer

    Version of Record online : 9 MAR 2006, DOI: 10.1111/j.1526-4637.2006.00083.x

  18. Accidental Death from Hydromorphone Ingestion

    Journal of Forensic Sciences

    Volume 56, Issue s1, January 2011, Pages: S271–S274, Robert Meatherall, Colin Lee and Susan Phillips

    Version of Record online : 15 NOV 2010, DOI: 10.1111/j.1556-4029.2010.01618.x

  19. A mathematical relationship for hydromorphone loading into liposomes with trans-membrane ammonium sulfate gradients

    Journal of Pharmaceutical Sciences

    Volume 99, Issue 6, June 2010, Pages: 2672–2680, Sheng Tu, Tamara McGinnis, Lisa Krugner-Higby and Timothy D. Heath

    Version of Record online : 15 DEC 2009, DOI: 10.1002/jps.22017

  20. You have free access to this content
    CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomes

    British Journal of Clinical Pharmacology

    Volume 57, Issue 3, March 2004, Pages: 287–297, Mark R. Hutchinson, Andrew Menelaou, David J. R. Foster, Janet K. Coller and Andrew A. Somogyi

    Version of Record online : 27 NOV 2003, DOI: 10.1046/j.1365-2125.2003.02002.x